FDA grants clearance for mobile AF detection algorithm

09.09.20141543
AliveCor Inc. announced that it has received clearance from the FDA for an algorithm designed to detect atrial fibrillation using a mobile device.

New ESC Guidelines on pulmonary embolism

08.09.20142338
ESC Guidelines on the management of patients with pulmonary embolism (PE) have been released during this congress and provide clinicians with a user-friendly summary of current evidence in the field.

Potent Statin Offers No Help After Cardiac Surgery

05.09.20141561
The powerful lipid-lowering drug rosuvastatin (Crestor) -- also purported to be an effective anti-inflammatory agent -- was powerless to prevent postoperative cardiac surgery complications such as atrial fibrillation in a randomized trial reported here.

Complete versus Lesion-only PRimary PCI Trial

04.09.20141582
Management of multivessel coronary disease during primary percutaneous coronary intervention (PCI) remains controversial. Current guidelines recommend treating the infarct-related artery.

BB-meta-HF: Efficacy of beta-blockers in heart failure patients with atrial fibrillation: Individual patient meta-analysis from the Beta-blockers in Heart Failure Collaborative Group

03.09.20141638
Atrial fibrillation (AF) and heart failure (HF) frequently coexist, causing substantial cardiovascular (CV) morbidity and mortality.

The British Heart Foundation Fractional Flow Reserve versus Angiography in Guiding Management to Optimise Outcomes in Non-ST-Segment Elevation Myocardial Infarction

02.09.20141753
We assessed the management and outcomes of non-ST segment elevation myocardial infarction (NSTEMI) patients randomly assigned to fractional flow reserve (FFR)-guided management or angiography-guided standard care.

Is There a Difference in STEMI Response Between Women and Men Undergoing PCI?

01.09.20141481
In age-matched women and men with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) with everolimus-eluting stents (ESS).
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.